LA JOLLA, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LA JOLLA INSTITUTE FOR IMMUNOLOGY, founded in 1988, is a mid-sized nonprofit that reported $75.6M in total revenue in fiscal year 2023. Revenue decreased 18% compared to the prior year. Expenses of $83.7M exceeded revenue, resulting in a 11% operating deficit.
AT LA JOLLA INSTITUTE FOR IMMUNOLOGY, OUR SCIENTISTS FOCUS ON UNDERSTANDING HOW THE IMMUNE SYSTEM WORKS IN ORDER TO PROMOTE HUMAN HEALTH AND PREVENT DISEASE. OUR DISCOVERIES APPLY TO MANY DISEASES, RANGING FROM DIABETES TO HEART DISEASE, INFECTIOUS DISEASES TO CANCER.
THE LA JOLLA INSTITUTE FOR IMMUNOLOGY ("LJI") IS A PRIVATE, NONPROFIT MEDICAL RESEARCH ORGANIZATION THAT IS RECOGNIZED AS A WORLD LEADER IN COMPREHENSIVE RESEARCH DEDICATED TO UNDERSTANDING THE...
THE LA JOLLA INSTITUTE FOR IMMUNOLOGY ("LJI") IS A PRIVATE, NONPROFIT MEDICAL RESEARCH ORGANIZATION THAT IS RECOGNIZED AS A WORLD LEADER IN COMPREHENSIVE RESEARCH DEDICATED TO UNDERSTANDING THE INTRICACIES AND POWER OF THE IMMUNE SYSTEM AND APPLYING THAT KNOWLEDGE TOWARD ITS GOAL OF LIFE WITHOUT DISEASE.THE INSTITUTE IS HOME TO 24 INDEPENDENT LABORATORIES, EACH OPERATED BY A LEADING SCIENTIST HANDPICKED FOR THEIR CREATIVITY AND PIONEERING SPIRIT. EACH OF THESE LABS IS DEDICATED TO UNDERSTANDING THE FAR-REACHING INFLUENCE OF THE IMMUNE SYSTEM AND TO TRAIN THE NEXT GENERATION OF SCIENTISTS, TO PROMOTE HUMAN HEALTH AND PREVENT A WIDE RANGE OF DISEASES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $75,554,472 | $92,274,481 | -0.2% |
| Expenses | $83,691,328 | $92,177,095 | -0.1% |
| Net Income | $-8,136,856 | $97,386 | -84.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ERICA SAPHIRE | PRESIDENT & CEO | 40.00 |
Officer
Director
|
$784,780 | $110,210 | $894,990 |
| MITCHELL KRONENBERG | DIR. & CHIEF SCI. OFFICER(END 9/23) | 40.00 |
Director
|
$406,198 | $74,840 | $481,038 |
| LINDA SHERMAN | DIRECTOR | 2.00 |
Director
|
$5,000 | $0 | $5,000 |
| ANTHONY R CARR | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| BARBARA DONNELL | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| CAROLEE LEE | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DAVID M RICKEY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DAVID R WEBB | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| EMILY HOLMES | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| FRANCOIS FERRE | DIRECTOR (END 02/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| FRED MILLER | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| GAIL K NAUGHTON | DIRECTOR, CHAIRMAN | 2.00 |
Director
|
$0 | $0 | $0 |
| GENEVIEVE T JACOBS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| J MARK WAXMAN | DIRECTOR (END 02/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN M CARETHERS | DIRECTOR (START 02/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| MARK V BOWLES | DIRECTOR (START 09/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| PAMELA K WASSERMAN | DIRECTOR (END 12/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| PAUL THIEL | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| RENETTA HAAS | DIRECTOR (START 12/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| RICHARD S BODMAN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ROBERT C DYNES | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SANDOR W SHAPERY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SANDRA SCHMID | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SUSAN DAVIS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| THOMAS L TULLIE | DIRECTOR (START 09/23) | 2.00 |
Director
|
$0 | $0 | $0 |
| YOSHIFUMI TORII | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| RICHARD STRYJEWSKI | CFO, TREASURER AND SECRETARY | 40.00 |
Officer
|
$302,026 | $61,068 | $363,094 |
| SHANE CROTTY | CHIEF SCI. OFFICER (START 09/23) | 40.00 |
Key Emp
|
$409,436 | $87,509 | $496,945 |
| JOHN KEEGAN | COO | 40.00 |
Key Emp
|
$298,258 | $67,756 | $366,014 |
| ALESSANDRO SETTE | DIVISION HEAD/CENTER HEAD/PROF | 40.00 |
Highest
|
$557,795 | $103,396 | $661,191 |
| MICHAEL CROFT | DIRECTOR, ACADEMIC AFFAIRS | 40.00 |
Highest
|
$390,575 | $80,091 | $470,666 |
| BJOERN PETERS | PROFESSOR | 40.00 |
Highest
|
$378,202 | $76,288 | $454,490 |
| STEPHEN P SCHOENBERGER | PROFESSOR | 40.00 |
Highest
|
$320,610 | $85,226 | $405,836 |
| HILDE CHEROUTRE | DIVISION HEAD/PROFESSOR | 40.00 |
Highest
|
$323,988 | $59,766 | $383,754 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $75,554,472 | $83,691,328 | $65,342,422 | $-8,136,856 |
| 2022 | $92,274,481 | $92,177,095 | $80,295,864 | $97,386 |
| 2021 | $102,015,351 | $85,939,425 | $70,149,069 | $16,075,926 |
| 2020 | $80,623,646 | $81,170,041 | $60,537,089 | $-546,395 |
| 2019 | $68,642,455 | $70,159,237 | $50,722,461 | $-1,516,782 |
Compare LA JOLLA INSTITUTE FOR IMMUNOLOGY with other nonprofits in California and across the country.